BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16829517)

  • 1. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.
    Nakerakanti SS; Kapanadze B; Yamasaki M; Markiewicz M; Trojanowska M
    J Biol Chem; 2006 Sep; 281(35):25259-69. PubMed ID: 16829517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of CCN2 by TGFbeta1 involves Ets-1.
    Van Beek JP; Kennedy L; Rockel JS; Bernier SM; Leask A
    Arthritis Res Ther; 2006; 8(2):R36. PubMed ID: 16469114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.
    Bujor AM; Nakerakanti S; Morris E; Hant FN; Trojanowska M
    Exp Dermatol; 2010 Apr; 19(4):347-54. PubMed ID: 20201953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli1 represses transcription of the human α2(I) collagen gene by recruitment of the HDAC1/p300 complex.
    Asano Y; Trojanowska M
    PLoS One; 2013; 8(9):e74930. PubMed ID: 24058639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation.
    Asano Y; Czuwara J; Trojanowska M
    J Biol Chem; 2007 Nov; 282(48):34672-83. PubMed ID: 17884818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta.
    Czuwara-Ladykowska J; Sementchenko VI; Watson DK; Trojanowska M
    J Biol Chem; 2002 Jun; 277(23):20399-408. PubMed ID: 11919190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.
    Mori Y; Hinchcliff M; Wu M; Warner-Blankenship M; M Lyons K; Varga J
    Exp Cell Res; 2008 Mar; 314(5):1094-104. PubMed ID: 18201696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
    Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
    J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts.
    Hattori T; Stawski L; Nakerakanti SS; Trojanowska M
    J Invest Dermatol; 2011 Jul; 131(7):1469-76. PubMed ID: 21451544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
    Phanish MK; Wahab NA; Hendry BM; Dockrell ME
    Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Yamane K; Tamaki K
    Nucleic Acids Res; 2005; 33(11):3540-9. PubMed ID: 15972796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.
    Geisinger MT; Astaiza R; Butler T; Popoff SN; Planey SL; Arnott JA
    PLoS One; 2012; 7(4):e35258. PubMed ID: 22539964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells.
    Svenson JL; Chike-Harris K; Amria MY; Nowling TK
    Genes Immun; 2010 Mar; 11(2):161-72. PubMed ID: 19829305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
    Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
    J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase.
    Black SA; Palamakumbura AH; Stan M; Trackman PC
    J Biol Chem; 2007 May; 282(21):15416-29. PubMed ID: 17428796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells.
    Gao R; Ball DK; Perbal B; Brigstock DR
    J Hepatol; 2004 Mar; 40(3):431-8. PubMed ID: 15123357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
    Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
    J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.
    Mott GA; Costales JA; Burleigh BA
    PLoS One; 2011; 6(9):e23482. PubMed ID: 21931601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.